Main Article Content

Abstract

Vulvovaginal candidiasis is a common fungal infection caused by Candida Sp,
especially Candida albicans. Recurrent vulvovaginal candidiasis was defined as
the occurrence of four or more episodes of vulvovaginal candidiasis in 12 months
period. As many as 9% of women from various populations have recurrent
vulvovaginal candidiasis. Vulvovaginal candidiasis affects the quality of life,
mental health, and sexual activity. There are many predisposing factors that
caused recurrent vulvovaginal candidiasis, such as genetics, host, habit,
idiopathic and non-albican candida microbes. Management of recurrent
vulvovaginal candidiasis includes elimination of predisposing factors; mycological
culture diagnosis and identification of specific Candida species; followed by
microbiological examination to confirm the sensitivity of the azole group to
Candida sp. Further, oral, or topical therapy should be continued until the patient
is asymptomatic and culture-negative. Patients should receive induction therapy
followed by maintenance suppressive therapy for six months.

Keywords

Recurrent Vulvovaginal Candidiasis Predisposing Factors Pathogenesis Management

Article Details

How to Cite
Sari Sovianti, C., & Mutia Devi. (2021). Recurrent Vulvovaginal Candidiasis. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 5(3), 498-507. https://doi.org/10.32539/bsm.v5i3.280